These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26708021)
21. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
22. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier. Chen YC; Hsieh WY; Lee WF; Zeng DT J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601 [TBL] [Abstract][Full Text] [Related]
23. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
24. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S; Sahoo SK Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969 [TBL] [Abstract][Full Text] [Related]
25. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094 [TBL] [Abstract][Full Text] [Related]
27. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model. Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833 [TBL] [Abstract][Full Text] [Related]
28. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
29. Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel. Ramanlal Chaudhari K; Kumar A; Megraj Khandelwal VK; Ukawala M; Manjappa AS; Mishra AK; Monkkonen J; Ramachandra Murthy RS J Control Release; 2012 Mar; 158(3):470-8. PubMed ID: 22146683 [TBL] [Abstract][Full Text] [Related]
30. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury. Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330 [TBL] [Abstract][Full Text] [Related]
31. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
33. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344 [TBL] [Abstract][Full Text] [Related]
34. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
35. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
36. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667 [TBL] [Abstract][Full Text] [Related]
37. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948 [TBL] [Abstract][Full Text] [Related]
38. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548 [TBL] [Abstract][Full Text] [Related]
39. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349 [TBL] [Abstract][Full Text] [Related]
40. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]